Source: Neuro-Oncology. Unidade: FMRP
Subjects: NEOPLASIAS CEREBRAIS, METILAÇÃO DE DNA, GLIOMA, MUTAÇÃO, ESTUDOS PROSPECTIVOS
ABNT
TESILEANU, C. Mircea S. et al. Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma. Neuro-Oncology, v. 23, n. 9, p. 1547-1559, 2021Tradução . . Disponível em: https://doi.org/10.1093/neuonc/noab088. Acesso em: 09 maio 2024.APA
Tesileanu, C. M. S., Van den Bent, M., Sanson, M., Wick, W., Brandes, A., Clement, P. M., et al. (2021). Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma. Neuro-Oncology, 23( 9), 1547-1559. doi:10.1093/neuonc/noab088NLM
Tesileanu CMS, Van den Bent M, Sanson M, Wick W, Brandes A, Clement PM, Erridge SC, Vogelbaum MA, Nowak A, Baurain J, Mason WP, Wheeler H, Chinot OL, Gill S, Griffin M, Rogers L, Taal W, Rudà R, Weller M, McBain C, Linde ME van, Sabedot TS, Hoogstrate Y, Deimling A von, Heer I de, IJcken WFJ van, Brouwer RWW, Aldape K, Jenkins RB, Dubbink H, Kros JM, Wesseling P, Cheung KJ, Golfinopoulos V, Baumert B, Gorlia T, Noushmehr H, French P. Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma [Internet]. Neuro-Oncology. 2021 ; 23( 9): 1547-1559.[citado 2024 maio 09 ] Available from: https://doi.org/10.1093/neuonc/noab088Vancouver
Tesileanu CMS, Van den Bent M, Sanson M, Wick W, Brandes A, Clement PM, Erridge SC, Vogelbaum MA, Nowak A, Baurain J, Mason WP, Wheeler H, Chinot OL, Gill S, Griffin M, Rogers L, Taal W, Rudà R, Weller M, McBain C, Linde ME van, Sabedot TS, Hoogstrate Y, Deimling A von, Heer I de, IJcken WFJ van, Brouwer RWW, Aldape K, Jenkins RB, Dubbink H, Kros JM, Wesseling P, Cheung KJ, Golfinopoulos V, Baumert B, Gorlia T, Noushmehr H, French P. Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma [Internet]. Neuro-Oncology. 2021 ; 23( 9): 1547-1559.[citado 2024 maio 09 ] Available from: https://doi.org/10.1093/neuonc/noab088